Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
int-snw-892 | chia-screen-data-Fav | 2.968 | 5.68e-17 | 8.94e-05 | 1.03e-03 | 17 | 15 |
reg-snw-8562 | chia-screen-data-Fav | 2.263 | 1.35e-07 | 3.15e-02 | 2.44e-02 | 32 | 24 |
int-snw-1029 | chia-screen-data-Fav | 2.959 | 7.22e-17 | 1.01e-04 | 1.12e-03 | 11 | 10 |
int-snw-6334 | chia-screen-data-Fav | 2.813 | 2.82e-15 | 6.25e-04 | 4.06e-03 | 16 | 14 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
CCNC | 892 | 2 | -1.726 | 2.968 | 101 | - | - |
ANAPC5 | 51433 | 6 | -1.264 | 2.263 | 239 | - | - |
CNOT1 | 23019 | 7 | -2.347 | 2.263 | 124 | Yes | - |
PHB2 | 11331 | 6 | -2.236 | 2.994 | 151 | Yes | - |
SCN8A | 6334 | 3 | -1.173 | 2.813 | 5 | - | - |
PHB | 5245 | 12 | -2.743 | 2.689 | 163 | Yes | Yes |
MED28 | 80306 | 6 | -2.404 | 2.445 | 86 | Yes | - |
ICT1 | 3396 | 3 | -2.210 | 2.813 | 208 | Yes | - |
TIA1 | 7072 | 4 | -1.234 | 2.263 | 53 | - | - |
CBLL1 | 79872 | 6 | -1.897 | 2.445 | 38 | - | - |
MED13L | 23389 | 8 | -2.550 | 2.307 | 50 | Yes | - |
VARS | 7407 | 8 | -2.366 | 2.689 | 204 | Yes | - |
APC | 324 | 6 | -2.293 | 3.004 | 384 | Yes | - |
POU5F1 | 5460 | 12 | -5.148 | 3.538 | 179 | Yes | Yes |
GSTP1 | 2950 | 3 | -2.251 | 2.955 | 59 | Yes | - |
MAPK14 | 1432 | 3 | -1.902 | 2.955 | 304 | - | - |
FBXO22 | 26263 | 8 | -1.739 | 2.459 | 208 | - | - |
DENR | 8562 | 4 | -1.023 | 2.263 | 42 | - | - |
E4F1 | 1877 | 3 | -2.370 | 2.959 | 27 | Yes | Yes |
PSMD2 | 5708 | 6 | -4.172 | 3.157 | 389 | Yes | Yes |
FOXJ3 | 22887 | 4 | -2.407 | 2.369 | 87 | Yes | Yes |
EIF2S2 | 8894 | 9 | -2.999 | 2.459 | 103 | Yes | Yes |
SUV39H2 | 79723 | 7 | -2.307 | 2.410 | 21 | Yes | Yes |
CASP2 | 835 | 4 | -2.007 | 2.445 | 47 | Yes | - |
MED12 | 9968 | 2 | -2.465 | 3.206 | 65 | Yes | - |
ETF1 | 2107 | 7 | -2.829 | 2.503 | 77 | Yes | Yes |
GTF3C3 | 9330 | 4 | -1.450 | 2.428 | 62 | - | - |
NAP1L4 | 4676 | 2 | -1.947 | 3.119 | 187 | - | - |
CCT7 | 10574 | 10 | -2.335 | 2.459 | 173 | Yes | - |
CPSF3 | 51692 | 7 | -2.686 | 2.503 | 31 | Yes | Yes |
HNRNPU | 3192 | 12 | -2.869 | 2.644 | 172 | Yes | - |
CLASP1 | 23332 | 4 | -2.365 | 2.459 | 39 | Yes | - |
NDUFA4L2 | 56901 | 10 | -2.477 | 2.459 | 21 | Yes | - |
HCFC1 | 3054 | 2 | -2.925 | 3.449 | 71 | Yes | Yes |
MED19 | 219541 | 4 | -2.657 | 3.449 | 115 | Yes | - |
AGPS | 8540 | 6 | -2.424 | 2.410 | 27 | Yes | Yes |
SLC7A5P1 | 81893 | 4 | -3.217 | 2.445 | 4 | Yes | - |
YAP1 | 10413 | 12 | -4.256 | 3.538 | 53 | Yes | - |
NCBP1 | 4686 | 8 | -2.510 | 2.459 | 84 | Yes | Yes |
SYNCRIP | 10492 | 8 | -2.401 | 2.503 | 247 | Yes | Yes |
LUC7L3 | 51747 | 4 | -3.523 | 3.449 | 18 | Yes | - |
ZDHHC20 | 253832 | 4 | -2.673 | 2.326 | 25 | Yes | - |
TADA2B | 93624 | 4 | -3.061 | 3.082 | 19 | Yes | - |
FTSJ1 | 24140 | 5 | -2.463 | 2.689 | 130 | Yes | Yes |
EIF2B2 | 8892 | 4 | -2.462 | 2.968 | 95 | Yes | Yes |
GSPT1 | 2935 | 7 | -2.313 | 2.503 | 47 | Yes | Yes |
SRSF3 | 6428 | 5 | -2.992 | 3.538 | 54 | Yes | - |
NFRKB | 4798 | 3 | -3.129 | 3.108 | 33 | Yes | Yes |
YY1 | 7528 | 3 | -2.572 | 3.120 | 168 | Yes | Yes |
NOLC1 | 9221 | 5 | -1.985 | 2.503 | 136 | - | - |
POLH | 5429 | 8 | -2.586 | 2.459 | 24 | Yes | Yes |
BTRC | 8945 | 4 | -1.144 | 2.263 | 64 | - | - |
DDIT3 | 1649 | 11 | -2.825 | 3.504 | 343 | Yes | Yes |
CDKN2A | 1029 | 3 | -1.774 | 2.959 | 126 | - | - |
FUBP1 | 8880 | 6 | -2.414 | 2.389 | 41 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
MAPK14 | 1432 | DDIT3 | 1649 | pp | -- | int.I2D: BCI, BioGrid, HPRD; int.HPRD: in vitro |
DENR | 8562 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
BTRC | 8945 | FOXJ3 | 22887 | pd | <> | reg.ITFP.txt: no annot |
ETF1 | 2107 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
NCBP1 | 4686 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
PHB | 5245 | VARS | 7407 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | GSTP1 | 2950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, BCI |
TIA1 | 7072 | CLASP1 | 23332 | pd | <> | reg.ITFP.txt: no annot |
APC | 324 | CCT7 | 10574 | pp | -- | int.I2D: Jorgensen_EphR, SOURAV_MAPK_LOW, IntAct |
EIF2B2 | 8892 | TADA2B | 93624 | pp | -- | int.I2D: BioGrid_Fly, BIND_Fly, FlyLow, IntAct_Fly, MINT_Fly |
APC | 324 | PHB | 5245 | pp | -- | int.I2D: Jorgensen_EphR |
ETF1 | 2107 | GSPT1 | 2935 | pp | -- | int.I2D: MINT, BCI, BioGrid, HPRD; int.Mint: MI:0915(physical association); int.HPRD: in vivo, yeast 2-hybrid |
CCNC | 892 | NAP1L4 | 4676 | pp | -- | int.I2D: BioGrid_Yeast |
ICT1 | 3396 | PHB | 5245 | pp | -- | int.I2D: BioGrid |
CDKN2A | 1029 | HNRNPU | 3192 | pp | -- | int.Intact: MI:0915(physical association) |
HNRNPU | 3192 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
DDIT3 | 1649 | NAP1L4 | 4676 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PSMD2 | 5708 | CNOT1 | 23019 | pp | -- | int.I2D: YeastLow |
DENR | 8562 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
CNOT1 | 23019 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
POLH | 5429 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
NOLC1 | 9221 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
NFRKB | 4798 | YY1 | 7528 | pp | -- | int.I2D: BioGrid |
MAPK14 | 1432 | BTRC | 8945 | pd | < | reg.ITFP.txt: no annot |
MAPK14 | 1432 | BTRC | 8945 | pp | -- | int.I2D: BioGrid |
GSPT1 | 2935 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
CDKN2A | 1029 | FTSJ1 | 24140 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
DENR | 8562 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
NCBP1 | 4686 | CBLL1 | 79872 | pd | < | reg.ITFP.txt: no annot |
CCT7 | 10574 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | GTF3C3 | 9330 | pd | < | reg.ITFP.txt: no annot |
CBLL1 | 79872 | MED28 | 80306 | pd | > | reg.ITFP.txt: no annot |
CDKN2A | 1029 | GSPT1 | 2935 | pp | -- | int.I2D: BCI; int.HPRD: in vitro, in vivo, yeast 2-hybrid |
PHB | 5245 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, IntAct_Yeast |
MED12 | 9968 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
VARS | 7407 | FTSJ1 | 24140 | pd | > | reg.ITFP.txt: no annot |
CCNC | 892 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MED12 | 9968 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
HCFC1 | 3054 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
CCNC | 892 | MED13L | 23389 | pp | -- | int.I2D: IntAct_Fly, MINT_Fly |
HNRNPU | 3192 | BTRC | 8945 | pp | -- | int.I2D: BCI, BioGrid, INNATEDB, HPRD; int.HPRD: in vivo |
PSMD2 | 5708 | VARS | 7407 | pp | -- | int.I2D: BioGrid_Yeast |
BTRC | 8945 | ZDHHC20 | 253832 | pd | > | reg.ITFP.txt: no annot |
MAPK14 | 1432 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
NAP1L4 | 4676 | FOXJ3 | 22887 | pd | < | reg.ITFP.txt: no annot |
APC | 324 | FOXJ3 | 22887 | pd | <> | reg.ITFP.txt: no annot |
MAPK14 | 1432 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
DDIT3 | 1649 | VARS | 7407 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MED28 | 80306 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
MAPK14 | 1432 | FUBP1 | 8880 | pp | -- | int.I2D: BioGrid |
AGPS | 8540 | SYNCRIP | 10492 | pd | < | reg.ITFP.txt: no annot |
MED13L | 23389 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
CASP2 | 835 | DENR | 8562 | pd | > | reg.ITFP.txt: no annot |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
ETF1 | 2107 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
BTRC | 8945 | CNOT1 | 23019 | pd | > | reg.ITFP.txt: no annot |
PSMD2 | 5708 | CCT7 | 10574 | pp | -- | int.I2D: BioGrid_Yeast |
PHB2 | 11331 | FTSJ1 | 24140 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
CCNC | 892 | EIF2B2 | 8892 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
DENR | 8562 | NOLC1 | 9221 | pd | < | reg.ITFP.txt: no annot |
EIF2B2 | 8892 | EIF2S2 | 8894 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh |
CDKN2A | 1029 | E4F1 | 1877 | pp | -- | int.I2D: BioGrid; int.HPRD: in vivo |
SYNCRIP | 10492 | CPSF3 | 51692 | pd | > | reg.ITFP.txt: no annot |
SRSF3 | 6428 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
EIF2S2 | 8894 | GTF3C3 | 9330 | pd | < | reg.ITFP.txt: no annot |
SYNCRIP | 10492 | SUV39H2 | 79723 | pd | > | reg.ITFP.txt: no annot |
MED13L | 23389 | ANAPC5 | 51433 | pd | < | reg.ITFP.txt: no annot |
CCNC | 892 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
PSMD2 | 5708 | EIF2B2 | 8892 | pp | -- | int.I2D: IntAct_Yeast |
TIA1 | 7072 | DENR | 8562 | pd | > | reg.ITFP.txt: no annot |
DDIT3 | 1649 | GSTP1 | 2950 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CDKN2A | 1029 | YY1 | 7528 | pd | < | reg.TRANSFAC.txt: no annot |
CDKN2A | 1029 | YY1 | 7528 | pp | -- | int.I2D: BioGrid, BIND, BCI |
CCNC | 892 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
CASP2 | 835 | SLC7A5P1 | 81893 | pd | > | reg.ITFP.txt: no annot |
MED13L | 23389 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
CASP2 | 835 | CBLL1 | 79872 | pd | <> | reg.ITFP.txt: no annot |
NOLC1 | 9221 | FTSJ1 | 24140 | pd | > | reg.ITFP.txt: no annot |
APC | 324 | BTRC | 8945 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, IntAct, INNATEDB |
GSPT1 | 2935 | NOLC1 | 9221 | pd | < | reg.ITFP.txt: no annot |
VARS | 7407 | FBXO22 | 26263 | pd | <> | reg.ITFP.txt: no annot |
CCNC | 892 | CNOT1 | 23019 | pp | -- | int.I2D: BioGrid_Yeast |
PHB | 5245 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
HNRNPU | 3192 | SYNCRIP | 10492 | pp | -- | int.Mint: MI:0915(physical association) |
MAPK14 | 1432 | SCN8A | 6334 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
ICT1 | 3396 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid |
FBXO22 | 26263 | NDUFA4L2 | 56901 | pd | > | reg.ITFP.txt: no annot |
PHB | 5245 | SCN8A | 6334 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
APC | 324 | SYNCRIP | 10492 | pp | -- | int.I2D: Jorgensen_EphR |
FUBP1 | 8880 | ANAPC5 | 51433 | pd | <> | reg.ITFP.txt: no annot |
ANAPC5 | 51433 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
EIF2S2 | 8894 | FBXO22 | 26263 | pd | < | reg.ITFP.txt: no annot |
DENR | 8562 | BTRC | 8945 | pd | < | reg.ITFP.txt: no annot |
BTRC | 8945 | YAP1 | 10413 | pp | -- | int.I2D: BioGrid, MINT; int.Mint: MI:0915(physical association) |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0005654 | nucleoplasm | 1.20e-09 | 1.97e-05 | 2.364 | 19 | 31 | 1095 |
GO:0010467 | gene expression | 3.43e-09 | 5.60e-05 | 2.734 | 15 | 27 | 669 |
GO:0005515 | protein binding | 2.53e-08 | 4.13e-04 | 0.990 | 41 | 77 | 6127 |
GO:0016592 | mediator complex | 1.08e-07 | 1.77e-03 | 5.406 | 5 | 5 | 35 |
GO:0044822 | poly(A) RNA binding | 1.75e-06 | 2.86e-02 | 2.046 | 15 | 27 | 1078 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.11e-05 | 1.82e-01 | 2.652 | 9 | 14 | 425 |
GO:0003723 | RNA binding | 2.31e-05 | 3.77e-01 | 2.741 | 8 | 15 | 355 |
GO:0003747 | translation release factor activity | 6.66e-05 | 1.00e+00 | 7.213 | 2 | 2 | 4 |
GO:0070461 | SAGA-type complex | 1.11e-04 | 1.00e+00 | 6.891 | 2 | 2 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.11e-04 | 1.00e+00 | 6.891 | 2 | 2 | 5 |
GO:0008380 | RNA splicing | 1.25e-04 | 1.00e+00 | 2.940 | 6 | 14 | 232 |
GO:0005739 | mitochondrion | 1.51e-04 | 1.00e+00 | 1.767 | 12 | 16 | 1046 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.66e-04 | 1.00e+00 | 6.628 | 2 | 2 | 6 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.84e-04 | 1.00e+00 | 4.754 | 3 | 3 | 33 |
GO:0000398 | mRNA splicing, via spliceosome | 2.30e-04 | 1.00e+00 | 3.169 | 5 | 9 | 165 |
GO:0044212 | transcription regulatory region DNA binding | 2.71e-04 | 1.00e+00 | 3.117 | 5 | 5 | 171 |
GO:0031124 | mRNA 3'-end processing | 3.79e-04 | 1.00e+00 | 4.406 | 3 | 4 | 42 |
GO:0005829 | cytosol | 4.56e-04 | 1.00e+00 | 1.138 | 19 | 38 | 2562 |
GO:0006369 | termination of RNA polymerase II transcription | 4.65e-04 | 1.00e+00 | 4.306 | 3 | 4 | 45 |
GO:0010225 | response to UV-C | 4.93e-04 | 1.00e+00 | 5.891 | 2 | 2 | 10 |
GO:0006379 | mRNA cleavage | 4.93e-04 | 1.00e+00 | 5.891 | 2 | 2 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 4.93e-04 | 1.00e+00 | 5.891 | 2 | 2 | 10 |
GO:0030529 | ribonucleoprotein complex | 5.85e-04 | 1.00e+00 | 3.380 | 4 | 6 | 114 |
GO:0003743 | translation initiation factor activity | 5.98e-04 | 1.00e+00 | 4.183 | 3 | 5 | 49 |
GO:0051010 | microtubule plus-end binding | 6.01e-04 | 1.00e+00 | 5.754 | 2 | 2 | 11 |
GO:0000209 | protein polyubiquitination | 6.25e-04 | 1.00e+00 | 3.355 | 4 | 5 | 116 |
GO:0008143 | poly(A) binding | 7.20e-04 | 1.00e+00 | 5.628 | 2 | 2 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 8.49e-04 | 1.00e+00 | 5.513 | 2 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 8.49e-04 | 1.00e+00 | 5.513 | 2 | 2 | 13 |
GO:0016071 | mRNA metabolic process | 9.09e-04 | 1.00e+00 | 2.734 | 5 | 8 | 223 |
GO:0031011 | Ino80 complex | 9.89e-04 | 1.00e+00 | 5.406 | 2 | 2 | 14 |
GO:0008013 | beta-catenin binding | 1.08e-03 | 1.00e+00 | 3.891 | 3 | 4 | 60 |
GO:0006479 | protein methylation | 1.14e-03 | 1.00e+00 | 5.306 | 2 | 2 | 15 |
GO:0006406 | mRNA export from nucleus | 1.19e-03 | 1.00e+00 | 3.844 | 3 | 5 | 62 |
GO:0003713 | transcription coactivator activity | 1.24e-03 | 1.00e+00 | 2.634 | 5 | 7 | 239 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.30e-03 | 1.00e+00 | 5.213 | 2 | 2 | 16 |
GO:0051276 | chromosome organization | 1.30e-03 | 1.00e+00 | 5.213 | 2 | 2 | 16 |
GO:0016070 | RNA metabolic process | 1.43e-03 | 1.00e+00 | 2.587 | 5 | 8 | 247 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.69e-03 | 1.00e+00 | 3.669 | 3 | 4 | 70 |
GO:0005634 | nucleus | 1.78e-03 | 1.00e+00 | 0.731 | 27 | 55 | 4828 |
GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity | 1.84e-03 | 1.00e+00 | 4.965 | 2 | 2 | 19 |
GO:0006974 | cellular response to DNA damage stimulus | 1.96e-03 | 1.00e+00 | 2.909 | 4 | 4 | 158 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.98e-03 | 1.00e+00 | 3.589 | 3 | 4 | 74 |
GO:0014003 | oligodendrocyte development | 2.04e-03 | 1.00e+00 | 4.891 | 2 | 3 | 20 |
GO:0031648 | protein destabilization | 2.25e-03 | 1.00e+00 | 4.821 | 2 | 2 | 21 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.39e-03 | 1.00e+00 | 3.494 | 3 | 4 | 79 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.47e-03 | 1.00e+00 | 4.754 | 2 | 2 | 22 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.93e-03 | 1.00e+00 | 2.070 | 6 | 7 | 424 |
GO:0003714 | transcription corepressor activity | 3.09e-03 | 1.00e+00 | 2.729 | 4 | 5 | 179 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 3.25e-03 | 1.00e+00 | 3.339 | 3 | 4 | 88 |
GO:0070126 | mitochondrial translational termination | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0097057 | TRAF2-GSTP1 complex | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0042483 | negative regulation of odontogenesis | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0031592 | centrosomal corona | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0097165 | nuclear stress granule | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0016150 | translation release factor activity, codon nonspecific | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0009794 | regulation of mitotic cell cycle, embryonic | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0070664 | negative regulation of leukocyte proliferation | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0035732 | nitric oxide storage | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0070026 | nitric oxide binding | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0035731 | dinitrosyl-iron complex binding | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0038066 | p38MAPK cascade | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0035730 | S-nitrosoglutathione binding | 3.37e-03 | 1.00e+00 | 8.213 | 1 | 1 | 1 |
GO:0031047 | gene silencing by RNA | 3.44e-03 | 1.00e+00 | 4.513 | 2 | 2 | 26 |
GO:0030331 | estrogen receptor binding | 3.71e-03 | 1.00e+00 | 4.458 | 2 | 2 | 27 |
GO:0001649 | osteoblast differentiation | 4.03e-03 | 1.00e+00 | 3.228 | 3 | 3 | 95 |
GO:0007094 | mitotic spindle assembly checkpoint | 4.87e-03 | 1.00e+00 | 4.259 | 2 | 3 | 31 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.51e-03 | 1.00e+00 | 1.550 | 8 | 13 | 811 |
GO:0006351 | transcription, DNA-templated | 5.71e-03 | 1.00e+00 | 1.168 | 12 | 17 | 1585 |
GO:0006446 | regulation of translational initiation | 6.53e-03 | 1.00e+00 | 4.043 | 2 | 2 | 36 |
GO:0042552 | myelination | 6.53e-03 | 1.00e+00 | 4.043 | 2 | 2 | 36 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 6.69e-03 | 1.00e+00 | 2.965 | 3 | 3 | 114 |
GO:0060242 | contact inhibition | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0045309 | protein phosphorylated amino acid binding | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0055105 | ubiquitin-protein transferase inhibitor activity | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0060965 | negative regulation of gene silencing by miRNA | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0030981 | cortical microtubule cytoskeleton | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0004832 | valine-tRNA ligase activity | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0006403 | RNA localization | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0008175 | tRNA methyltransferase activity | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0019207 | kinase regulator activity | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0001554 | luteolysis | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0034696 | response to prostaglandin F | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0051294 | establishment of spindle orientation | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0009798 | axis specification | 6.73e-03 | 1.00e+00 | 7.213 | 1 | 1 | 2 |
GO:0035019 | somatic stem cell maintenance | 8.01e-03 | 1.00e+00 | 3.891 | 2 | 2 | 40 |
GO:0005881 | cytoplasmic microtubule | 8.41e-03 | 1.00e+00 | 3.856 | 2 | 2 | 41 |
GO:0017148 | negative regulation of translation | 8.41e-03 | 1.00e+00 | 3.856 | 2 | 3 | 41 |
GO:0007050 | cell cycle arrest | 8.80e-03 | 1.00e+00 | 2.821 | 3 | 3 | 126 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0016149 | translation release factor activity, codon specific | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0004045 | aminoacyl-tRNA hydrolase activity | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0035726 | common myeloid progenitor cell proliferation | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0035986 | senescence-associated heterochromatin focus assembly | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:2000111 | positive regulation of macrophage apoptotic process | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 2 | 3 |
GO:0090400 | stress-induced premature senescence | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0035985 | senescence-associated heterochromatin focus | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.01e-02 | 1.00e+00 | 6.628 | 1 | 1 | 3 |
GO:0043525 | positive regulation of neuron apoptotic process | 1.05e-02 | 1.00e+00 | 3.690 | 2 | 2 | 46 |
GO:0000278 | mitotic cell cycle | 1.08e-02 | 1.00e+00 | 1.898 | 5 | 12 | 398 |
GO:0006355 | regulation of transcription, DNA-templated | 1.09e-02 | 1.00e+00 | 1.274 | 9 | 13 | 1104 |
GO:0048511 | rhythmic process | 1.09e-02 | 1.00e+00 | 3.658 | 2 | 2 | 47 |
GO:0019827 | stem cell maintenance | 1.14e-02 | 1.00e+00 | 3.628 | 2 | 2 | 48 |
GO:0016020 | membrane | 1.21e-02 | 1.00e+00 | 1.028 | 12 | 27 | 1746 |
GO:0005778 | peroxisomal membrane | 1.23e-02 | 1.00e+00 | 3.569 | 2 | 2 | 50 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.24e-02 | 1.00e+00 | 1.474 | 7 | 10 | 748 |
GO:0014044 | Schwann cell development | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 2 | 4 |
GO:0060913 | cardiac cell fate determination | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0046523 | S-methyl-5-thioribose-1-phosphate isomerase activity | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0019887 | protein kinase regulator activity | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0051716 | cellular response to stimulus | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 2 | 4 |
GO:2000774 | positive regulation of cellular senescence | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0008611 | ether lipid biosynthetic process | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0043515 | kinetochore binding | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0002192 | IRES-dependent translational initiation | 1.34e-02 | 1.00e+00 | 6.213 | 1 | 1 | 4 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.37e-02 | 1.00e+00 | 2.110 | 4 | 4 | 275 |
GO:0003677 | DNA binding | 1.38e-02 | 1.00e+00 | 1.135 | 10 | 16 | 1351 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.40e-02 | 1.00e+00 | 1.596 | 6 | 10 | 589 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.41e-02 | 1.00e+00 | 2.569 | 3 | 4 | 150 |
GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:1902510 | regulation of apoptotic DNA fragmentation | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0001714 | endodermal cell fate specification | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0003407 | neural retina development | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0005828 | kinetochore microtubule | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0034393 | positive regulation of smooth muscle cell apoptotic process | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0031023 | microtubule organizing center organization | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0097371 | MDM2/MDM4 family protein binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0051525 | NFAT protein binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0006449 | regulation of translational termination | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:1901741 | positive regulation of myoblast fusion | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0036124 | histone H3-K9 trimethylation | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 1 | 5 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1.69e-02 | 1.00e+00 | 3.330 | 2 | 2 | 59 |
GO:0006396 | RNA processing | 1.74e-02 | 1.00e+00 | 3.306 | 2 | 4 | 60 |
GO:0000776 | kinetochore | 1.91e-02 | 1.00e+00 | 3.236 | 2 | 4 | 63 |
GO:0030858 | positive regulation of epithelial cell differentiation | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 2 | 6 |
GO:0010564 | regulation of cell cycle process | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0050847 | progesterone receptor signaling pathway | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0032691 | negative regulation of interleukin-1 beta production | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 2 | 6 |
GO:0006333 | chromatin assembly or disassembly | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0002181 | cytoplasmic translation | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 3 | 6 |
GO:0000127 | transcription factor TFIIIC complex | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 2 | 6 |
GO:0008432 | JUN kinase binding | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0035497 | cAMP response element binding | 2.01e-02 | 1.00e+00 | 5.628 | 1 | 1 | 6 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.03e-02 | 1.00e+00 | 3.191 | 2 | 3 | 65 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.03e-02 | 1.00e+00 | 3.191 | 2 | 3 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 2.03e-02 | 1.00e+00 | 3.191 | 2 | 2 | 65 |
GO:0032930 | positive regulation of superoxide anion generation | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0042753 | positive regulation of circadian rhythm | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0004521 | endoribonuclease activity | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0010458 | exit from mitosis | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0046825 | regulation of protein export from nucleus | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 2 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0032790 | ribosome disassembly | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0006282 | regulation of DNA repair | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0035234 | ectopic germ cell programmed cell death | 2.34e-02 | 1.00e+00 | 5.406 | 1 | 1 | 7 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.37e-02 | 1.00e+00 | 1.607 | 5 | 6 | 487 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.41e-02 | 1.00e+00 | 2.274 | 3 | 5 | 184 |
GO:0044267 | cellular protein metabolic process | 2.52e-02 | 1.00e+00 | 1.584 | 5 | 7 | 495 |
GO:0003682 | chromatin binding | 2.59e-02 | 1.00e+00 | 1.829 | 4 | 7 | 334 |
GO:0007265 | Ras protein signal transduction | 2.64e-02 | 1.00e+00 | 2.984 | 2 | 2 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 2.64e-02 | 1.00e+00 | 2.984 | 2 | 2 | 75 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0045670 | regulation of osteoclast differentiation | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0042754 | negative regulation of circadian rhythm | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0000339 | RNA cap binding | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0010831 | positive regulation of myotube differentiation | 2.66e-02 | 1.00e+00 | 5.213 | 1 | 1 | 8 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 2.71e-02 | 1.00e+00 | 2.965 | 2 | 2 | 76 |
GO:0071013 | catalytic step 2 spliceosome | 2.91e-02 | 1.00e+00 | 2.909 | 2 | 3 | 79 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0008409 | 5'-3' exonuclease activity | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0048103 | somatic stem cell division | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0016591 | DNA-directed RNA polymerase II, holoenzyme | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0033598 | mammary gland epithelial cell proliferation | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0000302 | response to reactive oxygen species | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0019509 | L-methionine biosynthetic process from methylthioadenosine | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0000400 | four-way junction DNA binding | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0048188 | Set1C/COMPASS complex | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 1 | 9 |
GO:0032495 | response to muramyl dipeptide | 2.99e-02 | 1.00e+00 | 5.043 | 1 | 2 | 9 |
GO:0071222 | cellular response to lipopolysaccharide | 3.05e-02 | 1.00e+00 | 2.873 | 2 | 2 | 81 |
GO:0009952 | anterior/posterior pattern specification | 3.26e-02 | 1.00e+00 | 2.821 | 2 | 2 | 84 |
GO:0002199 | zona pellucida receptor complex | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0045667 | regulation of osteoblast differentiation | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0001518 | voltage-gated sodium channel complex | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0090399 | replicative senescence | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0008610 | lipid biosynthetic process | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0043194 | axon initial segment | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0031274 | positive regulation of pseudopodium assembly | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0006450 | regulation of translational fidelity | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0071949 | FAD binding | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0000731 | DNA synthesis involved in DNA repair | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0030877 | beta-catenin destruction complex | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 10 |
GO:0006415 | translational termination | 3.48e-02 | 1.00e+00 | 2.770 | 2 | 2 | 87 |
GO:0016032 | viral process | 3.49e-02 | 1.00e+00 | 1.458 | 5 | 16 | 540 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0031116 | positive regulation of microtubule polymerization | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0004535 | poly(A)-specific ribonuclease activity | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:2000036 | regulation of stem cell maintenance | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0005845 | mRNA cap binding complex | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0045663 | positive regulation of myoblast differentiation | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0071850 | mitotic cell cycle arrest | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0019395 | fatty acid oxidation | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0004707 | MAP kinase activity | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0033235 | positive regulation of protein sumoylation | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0035413 | positive regulation of catenin import into nucleus | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 3.65e-02 | 1.00e+00 | 4.754 | 1 | 1 | 11 |
GO:0050821 | protein stabilization | 3.77e-02 | 1.00e+00 | 2.705 | 2 | 3 | 91 |
GO:0016363 | nuclear matrix | 3.85e-02 | 1.00e+00 | 2.690 | 2 | 5 | 92 |
GO:0034453 | microtubule anchoring | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0061136 | regulation of proteasomal protein catabolic process | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0045295 | gamma-catenin binding | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0032886 | regulation of microtubule-based process | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0008334 | histone mRNA metabolic process | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0001953 | negative regulation of cell-matrix adhesion | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0016874 | ligase activity | 3.97e-02 | 1.00e+00 | 1.991 | 3 | 4 | 224 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 3.97e-02 | 1.00e+00 | 4.628 | 1 | 1 | 12 |
GO:0051082 | unfolded protein binding | 4.08e-02 | 1.00e+00 | 2.643 | 2 | 3 | 95 |
GO:0006364 | rRNA processing | 4.16e-02 | 1.00e+00 | 2.628 | 2 | 2 | 96 |
GO:0006915 | apoptotic process | 4.27e-02 | 1.00e+00 | 1.378 | 5 | 8 | 571 |
GO:0007140 | male meiosis | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0043508 | negative regulation of JUN kinase activity | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0030914 | STAGA complex | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0042974 | retinoic acid receptor binding | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0004708 | MAP kinase kinase activity | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0007067 | mitotic nuclear division | 4.29e-02 | 1.00e+00 | 1.946 | 3 | 4 | 231 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0044295 | axonal growth cone | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0035198 | miRNA binding | 4.29e-02 | 1.00e+00 | 4.513 | 1 | 1 | 13 |
GO:0030018 | Z disc | 4.31e-02 | 1.00e+00 | 2.598 | 2 | 2 | 98 |
GO:0006412 | translation | 4.47e-02 | 1.00e+00 | 1.922 | 3 | 5 | 235 |
GO:0007417 | central nervous system development | 4.55e-02 | 1.00e+00 | 2.555 | 2 | 2 | 101 |
GO:0035371 | microtubule plus-end | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0050905 | neuromuscular process | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0030889 | negative regulation of B cell proliferation | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0071480 | cellular response to gamma radiation | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0005685 | U1 snRNP | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0007020 | microtubule nucleation | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0045807 | positive regulation of endocytosis | 4.62e-02 | 1.00e+00 | 4.406 | 1 | 1 | 14 |
GO:0042809 | vitamin D receptor binding | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0043981 | histone H4-K5 acetylation | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0017091 | AU-rich element binding | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 2 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0043982 | histone H4-K8 acetylation | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0030014 | CCR4-NOT complex | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0060749 | mammary gland alveolus development | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0006376 | mRNA splice site selection | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0042307 | positive regulation of protein import into nucleus | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 2 | 15 |
GO:0005762 | mitochondrial large ribosomal subunit | 4.94e-02 | 1.00e+00 | 4.306 | 1 | 1 | 15 |
GO:0008134 | transcription factor binding | 5.00e-02 | 1.00e+00 | 1.856 | 3 | 6 | 246 |
GO:0033268 | node of Ranvier | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 1 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 1 | 16 |
GO:0005248 | voltage-gated sodium channel activity | 5.26e-02 | 1.00e+00 | 4.213 | 1 | 1 | 16 |
GO:0005730 | nucleolus | 5.28e-02 | 1.00e+00 | 0.817 | 10 | 28 | 1684 |
GO:0004842 | ubiquitin-protein transferase activity | 5.51e-02 | 1.00e+00 | 1.798 | 3 | 5 | 256 |
GO:0030308 | negative regulation of cell growth | 5.56e-02 | 1.00e+00 | 2.393 | 2 | 2 | 113 |
GO:0043274 | phospholipase binding | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0016409 | palmitoyltransferase activity | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0022624 | proteasome accessory complex | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0048593 | camera-type eye morphogenesis | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 2 | 17 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0001731 | formation of translation preinitiation complex | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 1 | 17 |
GO:0031122 | cytoplasmic microtubule organization | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 1 | 18 |
GO:0019228 | neuronal action potential | 5.90e-02 | 1.00e+00 | 4.043 | 1 | 1 | 18 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.22e-02 | 1.00e+00 | 3.965 | 1 | 1 | 19 |
GO:0071158 | positive regulation of cell cycle arrest | 6.22e-02 | 1.00e+00 | 3.965 | 1 | 1 | 19 |
GO:0043984 | histone H4-K16 acetylation | 6.22e-02 | 1.00e+00 | 3.965 | 1 | 1 | 19 |
GO:0000166 | nucleotide binding | 6.38e-02 | 1.00e+00 | 1.711 | 3 | 6 | 272 |
GO:0006325 | chromatin organization | 6.46e-02 | 1.00e+00 | 2.271 | 2 | 3 | 123 |
GO:0090398 | cellular senescence | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0018345 | protein palmitoylation | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0001578 | microtubule bundle formation | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0001502 | cartilage condensation | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0097194 | execution phase of apoptosis | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0005680 | anaphase-promoting complex | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0001227 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 6.53e-02 | 1.00e+00 | 3.891 | 1 | 1 | 20 |
GO:0006260 | DNA replication | 6.64e-02 | 1.00e+00 | 2.247 | 2 | 4 | 125 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 6.83e-02 | 1.00e+00 | 2.224 | 2 | 3 | 127 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0045648 | positive regulation of erythrocyte differentiation | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0045862 | positive regulation of proteolysis | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 2 | 21 |
GO:0000123 | histone acetyltransferase complex | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 2 | 21 |
GO:0004364 | glutathione transferase activity | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0042326 | negative regulation of phosphorylation | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0016575 | histone deacetylation | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0008637 | apoptotic mitochondrial changes | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0032757 | positive regulation of interleukin-8 production | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0009954 | proximal/distal pattern formation | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0000281 | mitotic cytokinesis | 6.85e-02 | 1.00e+00 | 3.821 | 1 | 1 | 21 |
GO:0030335 | positive regulation of cell migration | 7.11e-02 | 1.00e+00 | 2.191 | 2 | 2 | 130 |
GO:0030316 | osteoclast differentiation | 7.16e-02 | 1.00e+00 | 3.754 | 1 | 1 | 22 |
GO:0005720 | nuclear heterochromatin | 7.16e-02 | 1.00e+00 | 3.754 | 1 | 1 | 22 |
GO:0006378 | mRNA polyadenylation | 7.16e-02 | 1.00e+00 | 3.754 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 7.16e-02 | 1.00e+00 | 3.754 | 1 | 1 | 22 |
GO:0006413 | translational initiation | 7.21e-02 | 1.00e+00 | 2.180 | 2 | 4 | 131 |
GO:0034660 | ncRNA metabolic process | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 1 | 23 |
GO:0045787 | positive regulation of cell cycle | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 1 | 23 |
GO:0071346 | cellular response to interferon-gamma | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 2 | 23 |
GO:1901687 | glutathione derivative biosynthetic process | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 1 | 23 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 7.47e-02 | 1.00e+00 | 3.690 | 1 | 1 | 23 |
GO:0008135 | translation factor activity, nucleic acid binding | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 2 | 24 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 24 |
GO:0000086 | G2/M transition of mitotic cell cycle | 7.79e-02 | 1.00e+00 | 2.115 | 2 | 3 | 137 |
GO:0048147 | negative regulation of fibroblast proliferation | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 24 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 7.79e-02 | 1.00e+00 | 3.628 | 1 | 1 | 24 |
GO:0016567 | protein ubiquitination | 7.97e-02 | 1.00e+00 | 1.574 | 3 | 5 | 299 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0031519 | PcG protein complex | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0051059 | NF-kappaB binding | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 2 | 25 |
GO:0071479 | cellular response to ionizing radiation | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0086010 | membrane depolarization during action potential | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0030864 | cortical actin cytoskeleton | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0045296 | cadherin binding | 8.10e-02 | 1.00e+00 | 3.569 | 1 | 1 | 25 |
GO:0016055 | Wnt signaling pathway | 8.18e-02 | 1.00e+00 | 2.074 | 2 | 3 | 141 |
GO:0070979 | protein K11-linked ubiquitination | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 1 | 26 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 1 | 26 |
GO:0046966 | thyroid hormone receptor binding | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 1 | 26 |
GO:0035329 | hippo signaling | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 8.41e-02 | 1.00e+00 | 3.513 | 1 | 2 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 2 | 27 |
GO:0000387 | spliceosomal snRNP assembly | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0071339 | MLL1 complex | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0007422 | peripheral nervous system development | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0006913 | nucleocytoplasmic transport | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0007339 | binding of sperm to zona pellucida | 8.72e-02 | 1.00e+00 | 3.458 | 1 | 1 | 27 |
GO:0010628 | positive regulation of gene expression | 8.99e-02 | 1.00e+00 | 1.994 | 2 | 2 | 149 |
GO:0000077 | DNA damage checkpoint | 9.03e-02 | 1.00e+00 | 3.406 | 1 | 1 | 28 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 9.03e-02 | 1.00e+00 | 3.406 | 1 | 1 | 28 |
GO:0043022 | ribosome binding | 9.03e-02 | 1.00e+00 | 3.406 | 1 | 2 | 28 |
GO:2001235 | positive regulation of apoptotic signaling pathway | 9.03e-02 | 1.00e+00 | 3.406 | 1 | 1 | 28 |
GO:0008017 | microtubule binding | 9.09e-02 | 1.00e+00 | 1.984 | 2 | 4 | 150 |
GO:0042981 | regulation of apoptotic process | 9.19e-02 | 1.00e+00 | 1.975 | 2 | 3 | 151 |
GO:0019901 | protein kinase binding | 9.31e-02 | 1.00e+00 | 1.476 | 3 | 4 | 320 |
GO:0019005 | SCF ubiquitin ligase complex | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0007628 | adult walking behavior | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0071897 | DNA biosynthetic process | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0005913 | cell-cell adherens junction | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0016485 | protein processing | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0006749 | glutathione metabolic process | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0003887 | DNA-directed DNA polymerase activity | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 9.33e-02 | 1.00e+00 | 3.355 | 1 | 1 | 29 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 1 | 30 |
GO:0006370 | 7-methylguanosine mRNA capping | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 2 | 30 |
GO:0031647 | regulation of protein stability | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 2 | 30 |
GO:0010494 | cytoplasmic stress granule | 9.64e-02 | 1.00e+00 | 3.306 | 1 | 2 | 30 |
GO:0005525 | GTP binding | 9.85e-02 | 1.00e+00 | 1.440 | 3 | 5 | 328 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 9.94e-02 | 1.00e+00 | 3.259 | 1 | 1 | 31 |
GO:0005782 | peroxisomal matrix | 9.94e-02 | 1.00e+00 | 3.259 | 1 | 1 | 31 |
GO:0016604 | nuclear body | 9.94e-02 | 1.00e+00 | 3.259 | 1 | 1 | 31 |
GO:0070534 | protein K63-linked ubiquitination | 9.94e-02 | 1.00e+00 | 3.259 | 1 | 1 | 31 |
GO:0005737 | cytoplasm | 1.01e-01 | 1.00e+00 | 0.426 | 18 | 43 | 3976 |
GO:0042594 | response to starvation | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 3 | 32 |
GO:0034644 | cellular response to UV | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 1 | 32 |
GO:0002062 | chondrocyte differentiation | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 1 | 32 |
GO:0009953 | dorsal/ventral pattern formation | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 1 | 32 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 1.02e-01 | 1.00e+00 | 3.213 | 1 | 1 | 32 |
GO:0007162 | negative regulation of cell adhesion | 1.06e-01 | 1.00e+00 | 3.169 | 1 | 1 | 33 |
GO:0070830 | tight junction assembly | 1.06e-01 | 1.00e+00 | 3.169 | 1 | 1 | 33 |
GO:0033077 | T cell differentiation in thymus | 1.06e-01 | 1.00e+00 | 3.169 | 1 | 1 | 33 |
GO:0043407 | negative regulation of MAP kinase activity | 1.09e-01 | 1.00e+00 | 3.126 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 1.09e-01 | 1.00e+00 | 3.126 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 1.09e-01 | 1.00e+00 | 3.126 | 1 | 1 | 34 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 1 | 35 |
GO:0097192 | extrinsic apoptotic signaling pathway in absence of ligand | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 1 | 35 |
GO:0001942 | hair follicle development | 1.12e-01 | 1.00e+00 | 3.084 | 1 | 1 | 35 |
GO:0048538 | thymus development | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 36 |
GO:0030178 | negative regulation of Wnt signaling pathway | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 36 |
GO:0009267 | cellular response to starvation | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 1 | 37 |
GO:0016607 | nuclear speck | 1.18e-01 | 1.00e+00 | 1.762 | 2 | 6 | 175 |
GO:0001541 | ovarian follicle development | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 1 | 37 |
GO:0042752 | regulation of circadian rhythm | 1.18e-01 | 1.00e+00 | 3.004 | 1 | 3 | 37 |
GO:0007049 | cell cycle | 1.20e-01 | 1.00e+00 | 1.745 | 2 | 4 | 177 |
GO:0005667 | transcription factor complex | 1.21e-01 | 1.00e+00 | 1.737 | 2 | 3 | 178 |
GO:0051781 | positive regulation of cell division | 1.23e-01 | 1.00e+00 | 2.928 | 1 | 1 | 39 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.23e-01 | 1.00e+00 | 2.928 | 1 | 3 | 39 |
GO:0071407 | cellular response to organic cyclic compound | 1.23e-01 | 1.00e+00 | 2.928 | 1 | 3 | 39 |
GO:0019904 | protein domain specific binding | 1.24e-01 | 1.00e+00 | 1.713 | 2 | 2 | 181 |
GO:0043565 | sequence-specific DNA binding | 1.25e-01 | 1.00e+00 | 1.286 | 3 | 3 | 365 |
GO:0009408 | response to heat | 1.26e-01 | 1.00e+00 | 2.891 | 1 | 2 | 40 |
GO:0008285 | negative regulation of cell proliferation | 1.26e-01 | 1.00e+00 | 1.278 | 3 | 4 | 367 |
GO:0030521 | androgen receptor signaling pathway | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 41 |
GO:0045785 | positive regulation of cell adhesion | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 1 | 41 |
GO:0007519 | skeletal muscle tissue development | 1.29e-01 | 1.00e+00 | 2.856 | 1 | 2 | 41 |
GO:0006418 | tRNA aminoacylation for protein translation | 1.32e-01 | 1.00e+00 | 2.821 | 1 | 3 | 42 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 1.35e-01 | 1.00e+00 | 2.787 | 1 | 1 | 43 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.38e-01 | 1.00e+00 | 2.754 | 1 | 1 | 44 |
GO:0003712 | transcription cofactor activity | 1.38e-01 | 1.00e+00 | 2.754 | 1 | 1 | 44 |
GO:0050434 | positive regulation of viral transcription | 1.38e-01 | 1.00e+00 | 2.754 | 1 | 2 | 44 |
GO:0015030 | Cajal body | 1.41e-01 | 1.00e+00 | 2.721 | 1 | 1 | 45 |
GO:0016328 | lateral plasma membrane | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 1 | 46 |
GO:0044297 | cell body | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 1 | 46 |
GO:0043434 | response to peptide hormone | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 2 | 46 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 1 | 47 |
GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 1 | 47 |
GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage | 1.53e-01 | 1.00e+00 | 2.598 | 1 | 1 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.56e-01 | 1.00e+00 | 2.569 | 1 | 2 | 50 |
GO:0040008 | regulation of growth | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 51 |
GO:0003684 | damaged DNA binding | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 51 |
GO:0006986 | response to unfolded protein | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 2 | 51 |
GO:0000902 | cell morphogenesis | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 51 |
GO:0045732 | positive regulation of protein catabolic process | 1.58e-01 | 1.00e+00 | 2.541 | 1 | 1 | 51 |
GO:0045454 | cell redox homeostasis | 1.61e-01 | 1.00e+00 | 2.513 | 1 | 1 | 52 |
GO:0000775 | chromosome, centromeric region | 1.61e-01 | 1.00e+00 | 2.513 | 1 | 3 | 52 |
GO:0004197 | cysteine-type endopeptidase activity | 1.61e-01 | 1.00e+00 | 2.513 | 1 | 1 | 52 |
GO:0034976 | response to endoplasmic reticulum stress | 1.61e-01 | 1.00e+00 | 2.513 | 1 | 1 | 52 |
GO:0009611 | response to wounding | 1.64e-01 | 1.00e+00 | 2.485 | 1 | 1 | 53 |
GO:0060041 | retina development in camera-type eye | 1.64e-01 | 1.00e+00 | 2.485 | 1 | 1 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.64e-01 | 1.00e+00 | 2.485 | 1 | 2 | 53 |
GO:0051403 | stress-activated MAPK cascade | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 2 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 1 | 54 |
GO:0005524 | ATP binding | 1.68e-01 | 1.00e+00 | 0.617 | 7 | 13 | 1354 |
GO:0002039 | p53 binding | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 3 | 55 |
GO:0000226 | microtubule cytoskeleton organization | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 2 | 55 |
GO:0006814 | sodium ion transport | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 1 | 55 |
GO:0000932 | cytoplasmic mRNA processing body | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 2 | 56 |
GO:0000724 | double-strand break repair via homologous recombination | 1.75e-01 | 1.00e+00 | 2.380 | 1 | 1 | 57 |
GO:0005622 | intracellular | 1.77e-01 | 1.00e+00 | 1.393 | 2 | 2 | 226 |
GO:0000502 | proteasome complex | 1.78e-01 | 1.00e+00 | 2.355 | 1 | 2 | 58 |
GO:0035725 | sodium ion transmembrane transport | 1.78e-01 | 1.00e+00 | 2.355 | 1 | 1 | 58 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.89e-01 | 1.00e+00 | 2.259 | 1 | 1 | 62 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1.89e-01 | 1.00e+00 | 2.259 | 1 | 2 | 62 |
GO:0000151 | ubiquitin ligase complex | 1.92e-01 | 1.00e+00 | 2.236 | 1 | 2 | 63 |
GO:0006417 | regulation of translation | 1.92e-01 | 1.00e+00 | 2.236 | 1 | 1 | 63 |
GO:0019903 | protein phosphatase binding | 1.92e-01 | 1.00e+00 | 2.236 | 1 | 1 | 63 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 2 | 64 |
GO:0009749 | response to glucose | 1.95e-01 | 1.00e+00 | 2.213 | 1 | 2 | 64 |
GO:0034146 | toll-like receptor 5 signaling pathway | 1.97e-01 | 1.00e+00 | 2.191 | 1 | 2 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 1.97e-01 | 1.00e+00 | 2.191 | 1 | 2 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 2.00e-01 | 1.00e+00 | 2.169 | 1 | 1 | 66 |
GO:0009636 | response to toxic substance | 2.00e-01 | 1.00e+00 | 2.169 | 1 | 1 | 66 |
GO:0007409 | axonogenesis | 2.00e-01 | 1.00e+00 | 2.169 | 1 | 1 | 66 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.03e-01 | 1.00e+00 | 2.147 | 1 | 3 | 67 |
GO:0006310 | DNA recombination | 2.03e-01 | 1.00e+00 | 2.147 | 1 | 2 | 67 |
GO:0000777 | condensed chromosome kinetochore | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 68 |
GO:0006338 | chromatin remodeling | 2.05e-01 | 1.00e+00 | 2.126 | 1 | 1 | 68 |
GO:0003697 | single-stranded DNA binding | 2.08e-01 | 1.00e+00 | 2.105 | 1 | 2 | 69 |
GO:0018105 | peptidyl-serine phosphorylation | 2.08e-01 | 1.00e+00 | 2.105 | 1 | 1 | 69 |
GO:0043025 | neuronal cell body | 2.11e-01 | 1.00e+00 | 1.224 | 2 | 3 | 254 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 2 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 2.14e-01 | 1.00e+00 | 2.063 | 1 | 2 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 2 | 72 |
GO:0032587 | ruffle membrane | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 1 | 72 |
GO:0010468 | regulation of gene expression | 2.16e-01 | 1.00e+00 | 2.043 | 1 | 1 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 2.19e-01 | 1.00e+00 | 2.023 | 1 | 2 | 73 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.19e-01 | 1.00e+00 | 2.023 | 1 | 2 | 73 |
GO:0003729 | mRNA binding | 2.19e-01 | 1.00e+00 | 2.023 | 1 | 3 | 73 |
GO:0000785 | chromatin | 2.19e-01 | 1.00e+00 | 2.023 | 1 | 2 | 73 |
GO:0042826 | histone deacetylase binding | 2.21e-01 | 1.00e+00 | 2.004 | 1 | 2 | 74 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 2.21e-01 | 1.00e+00 | 2.004 | 1 | 2 | 74 |
GO:0002020 | protease binding | 2.21e-01 | 1.00e+00 | 2.004 | 1 | 1 | 74 |
GO:0006281 | DNA repair | 2.23e-01 | 1.00e+00 | 1.169 | 2 | 4 | 264 |
GO:0001843 | neural tube closure | 2.24e-01 | 1.00e+00 | 1.984 | 1 | 1 | 75 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 2.24e-01 | 1.00e+00 | 1.984 | 1 | 1 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 2.27e-01 | 1.00e+00 | 1.965 | 1 | 2 | 76 |
GO:0042802 | identical protein binding | 2.29e-01 | 1.00e+00 | 0.858 | 3 | 6 | 491 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.29e-01 | 1.00e+00 | 1.946 | 1 | 2 | 77 |
GO:0008584 | male gonad development | 2.29e-01 | 1.00e+00 | 1.946 | 1 | 1 | 77 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 2.29e-01 | 1.00e+00 | 1.946 | 1 | 2 | 77 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 2.29e-01 | 1.00e+00 | 1.946 | 1 | 2 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 2.32e-01 | 1.00e+00 | 1.928 | 1 | 2 | 78 |
GO:0001822 | kidney development | 2.35e-01 | 1.00e+00 | 1.909 | 1 | 2 | 79 |
GO:0006334 | nucleosome assembly | 2.35e-01 | 1.00e+00 | 1.909 | 1 | 3 | 79 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.35e-01 | 1.00e+00 | 1.120 | 2 | 2 | 273 |
GO:0043065 | positive regulation of apoptotic process | 2.36e-01 | 1.00e+00 | 1.115 | 2 | 3 | 274 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 2.37e-01 | 1.00e+00 | 1.891 | 1 | 3 | 80 |
GO:0034138 | toll-like receptor 3 signaling pathway | 2.37e-01 | 1.00e+00 | 1.891 | 1 | 2 | 80 |
GO:0051301 | cell division | 2.40e-01 | 1.00e+00 | 1.873 | 1 | 2 | 81 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.40e-01 | 1.00e+00 | 1.873 | 1 | 2 | 81 |
GO:0007517 | muscle organ development | 2.45e-01 | 1.00e+00 | 1.838 | 1 | 1 | 83 |
GO:0019899 | enzyme binding | 2.53e-01 | 1.00e+00 | 1.043 | 2 | 3 | 288 |
GO:0009653 | anatomical structure morphogenesis | 2.55e-01 | 1.00e+00 | 1.770 | 1 | 1 | 87 |
GO:0006464 | cellular protein modification process | 2.60e-01 | 1.00e+00 | 1.737 | 1 | 1 | 89 |
GO:0005777 | peroxisome | 2.63e-01 | 1.00e+00 | 1.721 | 1 | 1 | 90 |
GO:0000187 | activation of MAPK activity | 2.63e-01 | 1.00e+00 | 1.721 | 1 | 2 | 90 |
GO:0000922 | spindle pole | 2.65e-01 | 1.00e+00 | 1.705 | 1 | 1 | 91 |
GO:0016337 | single organismal cell-cell adhesion | 2.68e-01 | 1.00e+00 | 1.690 | 1 | 1 | 92 |
GO:0006928 | cellular component movement | 2.68e-01 | 1.00e+00 | 1.690 | 1 | 1 | 92 |
GO:0005743 | mitochondrial inner membrane | 2.68e-01 | 1.00e+00 | 0.984 | 2 | 3 | 300 |
GO:0005923 | tight junction | 2.68e-01 | 1.00e+00 | 1.690 | 1 | 1 | 92 |
GO:0043234 | protein complex | 2.68e-01 | 1.00e+00 | 0.984 | 2 | 4 | 300 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.73e-01 | 1.00e+00 | 1.658 | 1 | 2 | 94 |
GO:0005770 | late endosome | 2.73e-01 | 1.00e+00 | 1.658 | 1 | 1 | 94 |
GO:0034142 | toll-like receptor 4 signaling pathway | 2.77e-01 | 1.00e+00 | 1.628 | 1 | 2 | 96 |
GO:0071456 | cellular response to hypoxia | 2.82e-01 | 1.00e+00 | 1.598 | 1 | 2 | 98 |
GO:0006470 | protein dephosphorylation | 2.85e-01 | 1.00e+00 | 1.584 | 1 | 1 | 99 |
GO:0008270 | zinc ion binding | 2.90e-01 | 1.00e+00 | 0.476 | 5 | 11 | 1067 |
GO:0051726 | regulation of cell cycle | 2.92e-01 | 1.00e+00 | 1.541 | 1 | 4 | 102 |
GO:0030154 | cell differentiation | 3.00e-01 | 1.00e+00 | 0.869 | 2 | 2 | 325 |
GO:0007411 | axon guidance | 3.02e-01 | 1.00e+00 | 0.860 | 2 | 2 | 327 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 3.04e-01 | 1.00e+00 | 1.472 | 1 | 1 | 107 |
GO:0006935 | chemotaxis | 3.06e-01 | 1.00e+00 | 1.458 | 1 | 1 | 108 |
GO:0008283 | cell proliferation | 3.07e-01 | 1.00e+00 | 0.842 | 2 | 3 | 331 |
GO:0002224 | toll-like receptor signaling pathway | 3.09e-01 | 1.00e+00 | 1.445 | 1 | 2 | 109 |
GO:0005938 | cell cortex | 3.09e-01 | 1.00e+00 | 1.445 | 1 | 1 | 109 |
GO:0006461 | protein complex assembly | 3.13e-01 | 1.00e+00 | 1.419 | 1 | 2 | 111 |
GO:0007605 | sensory perception of sound | 3.13e-01 | 1.00e+00 | 1.419 | 1 | 1 | 111 |
GO:0005813 | centrosome | 3.17e-01 | 1.00e+00 | 0.808 | 2 | 4 | 339 |
GO:0034765 | regulation of ion transmembrane transport | 3.18e-01 | 1.00e+00 | 1.393 | 1 | 1 | 113 |
GO:0005819 | spindle | 3.20e-01 | 1.00e+00 | 1.380 | 1 | 2 | 114 |
GO:0097190 | apoptotic signaling pathway | 3.25e-01 | 1.00e+00 | 1.355 | 1 | 1 | 116 |
GO:0006006 | glucose metabolic process | 3.32e-01 | 1.00e+00 | 1.318 | 1 | 1 | 119 |
GO:0007568 | aging | 3.41e-01 | 1.00e+00 | 1.271 | 1 | 2 | 123 |
GO:0007219 | Notch signaling pathway | 3.45e-01 | 1.00e+00 | 1.247 | 1 | 2 | 125 |
GO:0006805 | xenobiotic metabolic process | 3.54e-01 | 1.00e+00 | 1.202 | 1 | 1 | 129 |
GO:0030027 | lamellipodium | 3.56e-01 | 1.00e+00 | 1.191 | 1 | 1 | 130 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 3.56e-01 | 1.00e+00 | 1.191 | 1 | 1 | 130 |
GO:0016477 | cell migration | 3.59e-01 | 1.00e+00 | 1.180 | 1 | 2 | 131 |
GO:0046983 | protein dimerization activity | 3.59e-01 | 1.00e+00 | 1.180 | 1 | 1 | 131 |
GO:0031982 | vesicle | 3.65e-01 | 1.00e+00 | 1.147 | 1 | 2 | 134 |
GO:0044255 | cellular lipid metabolic process | 3.78e-01 | 1.00e+00 | 1.084 | 1 | 1 | 140 |
GO:0007507 | heart development | 3.80e-01 | 1.00e+00 | 1.074 | 1 | 2 | 141 |
GO:0006457 | protein folding | 3.97e-01 | 1.00e+00 | 0.994 | 1 | 1 | 149 |
GO:0007166 | cell surface receptor signaling pathway | 3.97e-01 | 1.00e+00 | 0.994 | 1 | 1 | 149 |
GO:0008022 | protein C-terminus binding | 4.21e-01 | 1.00e+00 | 0.882 | 1 | 1 | 161 |
GO:0043066 | negative regulation of apoptotic process | 4.31e-01 | 1.00e+00 | 0.455 | 2 | 5 | 433 |
GO:0007420 | brain development | 4.42e-01 | 1.00e+00 | 0.787 | 1 | 1 | 172 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.52e-01 | 1.00e+00 | 0.745 | 1 | 3 | 177 |
GO:0031625 | ubiquitin protein ligase binding | 4.57e-01 | 1.00e+00 | 0.721 | 1 | 2 | 180 |
GO:0043547 | positive regulation of GTPase activity | 4.75e-01 | 1.00e+00 | 0.643 | 1 | 2 | 190 |
GO:0004872 | receptor activity | 4.91e-01 | 1.00e+00 | 0.576 | 1 | 1 | 199 |
GO:0001525 | angiogenesis | 4.93e-01 | 1.00e+00 | 0.569 | 1 | 1 | 200 |
GO:0003924 | GTPase activity | 4.98e-01 | 1.00e+00 | 0.548 | 1 | 2 | 203 |
GO:0030168 | platelet activation | 5.02e-01 | 1.00e+00 | 0.534 | 1 | 1 | 205 |
GO:0001701 | in utero embryonic development | 5.10e-01 | 1.00e+00 | 0.499 | 1 | 2 | 210 |
GO:0006184 | GTP catabolic process | 5.27e-01 | 1.00e+00 | 0.432 | 1 | 2 | 220 |
GO:0030425 | dendrite | 5.58e-01 | 1.00e+00 | 0.306 | 1 | 1 | 240 |
GO:0007399 | nervous system development | 5.65e-01 | 1.00e+00 | 0.276 | 1 | 3 | 245 |
GO:0005874 | microtubule | 5.84e-01 | 1.00e+00 | 0.202 | 1 | 3 | 258 |
GO:0003779 | actin binding | 6.08e-01 | 1.00e+00 | 0.110 | 1 | 1 | 275 |
GO:0007283 | spermatogenesis | 6.09e-01 | 1.00e+00 | 0.105 | 1 | 1 | 276 |
GO:0006954 | inflammatory response | 6.26e-01 | 1.00e+00 | 0.038 | 1 | 1 | 289 |
GO:0007165 | signal transduction | 6.28e-01 | 1.00e+00 | -0.094 | 3 | 8 | 950 |
GO:0004674 | protein serine/threonine kinase activity | 6.55e-01 | 1.00e+00 | -0.072 | 1 | 2 | 312 |
GO:0035556 | intracellular signal transduction | 6.61e-01 | 1.00e+00 | -0.095 | 1 | 2 | 317 |
GO:0005575 | cellular_component | 6.66e-01 | 1.00e+00 | -0.118 | 1 | 1 | 322 |
GO:0043231 | intracellular membrane-bounded organelle | 6.78e-01 | 1.00e+00 | -0.162 | 1 | 1 | 332 |
GO:0005925 | focal adhesion | 7.17e-01 | 1.00e+00 | -0.318 | 1 | 2 | 370 |
GO:0007155 | cell adhesion | 7.31e-01 | 1.00e+00 | -0.372 | 1 | 2 | 384 |
GO:0046872 | metal ion binding | 7.40e-01 | 1.00e+00 | -0.304 | 4 | 6 | 1465 |
GO:0046982 | protein heterodimerization activity | 7.44e-01 | 1.00e+00 | -0.427 | 1 | 3 | 399 |
GO:0006508 | proteolysis | 7.54e-01 | 1.00e+00 | -0.466 | 1 | 2 | 410 |
GO:0009986 | cell surface | 7.64e-01 | 1.00e+00 | -0.508 | 1 | 4 | 422 |
GO:0070062 | extracellular vesicular exosome | 7.64e-01 | 1.00e+00 | -0.276 | 7 | 15 | 2516 |
GO:0007596 | blood coagulation | 7.96e-01 | 1.00e+00 | -0.645 | 1 | 1 | 464 |
GO:0055114 | oxidation-reduction process | 8.08e-01 | 1.00e+00 | -0.697 | 1 | 2 | 481 |
GO:0044281 | small molecule metabolic process | 8.23e-01 | 1.00e+00 | -0.541 | 3 | 12 | 1295 |
GO:0003674 | molecular_function | 8.34e-01 | 1.00e+00 | -0.820 | 1 | 1 | 524 |
GO:0005615 | extracellular space | 8.63e-01 | 1.00e+00 | -0.767 | 2 | 4 | 1010 |
GO:0005783 | endoplasmic reticulum | 8.77e-01 | 1.00e+00 | -1.040 | 1 | 2 | 610 |
GO:0045087 | innate immune response | 8.80e-01 | 1.00e+00 | -1.054 | 1 | 4 | 616 |
GO:0005794 | Golgi apparatus | 8.93e-01 | 1.00e+00 | -1.131 | 1 | 1 | 650 |
GO:0005886 | plasma membrane | 9.33e-01 | 1.00e+00 | -0.671 | 6 | 14 | 2834 |
GO:0005887 | integral component of plasma membrane | 9.65e-01 | 1.00e+00 | -1.695 | 1 | 1 | 961 |
GO:0016021 | integral component of membrane | 9.99e-01 | 1.00e+00 | -2.065 | 2 | 7 | 2483 |